Lv4
450 积分 2021-01-26 加入
Perioperative camrelizumab plus rivoceranib versus surgery alone in patients with resectable hepatocellular carcinoma at intermediate or high risk of recurrence (CARES-009): a randomised phase 2/3 trial
10天前
已完结
Stage Hepatocellular Carcinoma—Lessons From the TORCH Trial
22天前
已完结
Transarterial Chemoembolization Plus Thermal Ablation in Unresectable Hepatocellular Carcinoma: The Phase 3 TORCH Randomized Clinical Trial
22天前
已完结
CLIM-TIME identifies metastatic microenvironment modulators for T cell therapy response
25天前
已完结
Spatiotemporal multiomics uncover tumor ecosystem dynamics during metastatic colonization
26天前
已完结
Safety and efficacy of subcutaneous injection with HMI-115 versus placebo in endometriosis-associated pain in premenopausal women: a multicentre, double-blind, randomised, proof-of-concept phase 2 trial
1个月前
已完结
mRNA vaccines for hepatocellular carcinoma: mechanisms, therapeutic strategies, and clinical perspectives
1个月前
已完结
Atezolizumab plus personalized neoantigen vaccination in urothelial cancer: a phase 1 trial
1个月前
已完结
High resolution spatial transcriptomics identifies insufficient radiofrequency ablation induces hepatocellular carcinoma progression via CEBPD / CXCL2 axis
1个月前
已关闭
Combination locoregional and systemic therapies in hepatocellular carcinoma
3个月前
已完结
皖公网安备34019202002308
